Study summary

An anti-inflammatory drug, ibudilast, did not reduce heavy drinking

Ibudilast trial · 102 people, phase 2 · Published April 2025, JAMA Network Open

What was tested

Ibudilast, a neuroimmune modulator, or placebo for 12 weeks in treatment-seeking adults with moderate or severe alcohol use disorder.

What they found

What it means

Brain-inflammation drugs remain under study but this one did not work overall.

JAMA Netw Open, via PubMed ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.